Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Epilepsia Open ; 6(2): 437-442, 2021 06.
Article in English | MEDLINE | ID: covidwho-1222614

ABSTRACT

OBJECTIVE: Hyperventilation (HV) is one of the main and basic activation methods during ambulatory electroencephalogram (EEG), unless medical reasons contraindicate it. During the COVID-19 pandemic, with the high risk of human-to-human infection, local guidelines and recommendations have been developed that suggest not to perform the HV maneuver routinely. Our objective was to characterize patients who present positive HV in an epilepsy center. METHODS: We analyzed retrospectively all the ambulatory EEGs performed during one year in our specialized ambulatory child and adolescent epilepsy center, and describe patients with positive maneuver. RESULTS: A total of 305 EEGs were performed. Patients under 3 years and 11 months were excluded as well as all patients that did not fill up the criteria for epilepsy diagnosis. From the 252 EEGs that were included in the study, 194 EEGs (77%) were classified as abnormal and 58 (23%) as normal. From these same 252 EEGs, 150 EEG finished correctly the HV maneuver. Physiological slowing response was found in 54 EEGs (36%), no changes (negative) in 83 (55%), and abnormal response (positive) in 13 EEGs (9%). The 13 HV-positive EEGs showed 4 patients with an increase of epileptiform activity, 3 patients experienced an increase of basal preregistered abnormal slowing, and 6 EEGs showed trigger of bilaterally synchronous and symmetric 2-4 Hz spike-and-slow wave discharges and absences. None of these last 6 patients needed more than 3 minutes to elicit the paroxysmal discharge. SIGNIFICANCE: Based on these findings and according with other studies, the low positivity and high specificity of the HV maneuver support the idea that HV could be excluded during the COVID-19 pandemic situation, and also reevaluate whether it could be changed to a complementary maneuver, restricted only for cases where absence epilepsy is suspected. Larger studies will be needed to reaffirm this proposal.


Subject(s)
Ambulatory Care , COVID-19 , Electroencephalography/methods , Epilepsy, Absence , Adolescent , Ambulatory Care/methods , Ambulatory Care/statistics & numerical data , COVID-19/epidemiology , COVID-19/prevention & control , Child , Chile/epidemiology , Diagnostic Techniques, Neurological/standards , Diagnostic Techniques, Neurological/trends , Epilepsy, Absence/diagnosis , Epilepsy, Absence/epidemiology , Epilepsy, Absence/physiopathology , Female , Humans , Hyperventilation , Male , Retrospective Studies , SARS-CoV-2 , Seizures/diagnosis , Seizures/physiopathology , Sensitivity and Specificity
2.
Epilepsy Behav ; 115: 107404, 2021 02.
Article in English | MEDLINE | ID: covidwho-972215

ABSTRACT

The diagnosis of childhood absence epilepsy (CAE) is typically based on history and description of spells, supported by an office-based positive hyperventilation test and confirmed by routine electroencephalography (EEG). In the current coronavirus disease 2019 (COVID-19) pandemic, many pediatric neurologists have switched to telemedicine visits for nonemergent outpatient evaluations. We present a series of children diagnosed as having CAE on the basis of a positive hyperventilation test performed during remote televisits. Several of these children were begun on treatment for CAE prior to obtaining an EEG, with significant seizure reduction. Our series documents the feasibility of CAE diagnosis and management by telemedicine.


Subject(s)
Anticonvulsants/therapeutic use , COVID-19/prevention & control , Disease Management , Epilepsy, Absence/diagnosis , Epilepsy, Absence/drug therapy , Telemedicine/methods , COVID-19/epidemiology , Child , Child, Preschool , Electroencephalography/methods , Electroencephalography/trends , Epilepsy, Absence/epidemiology , Female , Humans , Hyperventilation/diagnosis , Hyperventilation/epidemiology , Male , Neurologists/trends , Pediatricians/trends , SARS-CoV-2 , Telemedicine/trends , Valproic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL